Associated Papers
EGFR transcript variants: Potential diagnostic biomarker for glioblastoma, IDH-wildtype?
Cook DJ et al.
Journal of Neuropathology and Experimental Neurology, 2025
Clinical utility of targeted RNA sequencing in cancer molecular diagnostics.
Siddaway R et al.
Nature Medicine, 2025
Integrated analyses reveal two molecularly and clinically distinct subtypes of H3 K27M-mutant diffuse midline gliomas with prognostic significance.
Stegat L et al.
Acta Neuropathologica, 2024
Novel EGFR mutations in diffuse midline gliomas using cost-effective strategies: A report of 2 cases.
Dandapath I et al.
Neuro-oncology Practice, 2024
Discovery and Validation of Survival-Specific Genes in Papillary Renal Cell Carcinoma Using a Customized Next-Generation Sequencing Gene Panel.
Hwang J et al.
Cancers, 2024
38893126 (PubMed )
Supplement: cancers-16-02006-s001.zip › Supplementary_file_TCGA-KIRP_293_patients_and_47_survival_genes.xlsx › TCGA_293_clinical_gene_mut
Comprehensive mutational scanning of EGFR reveals TKI sensitivities of extracellular domain mutants.
Hayes TK et al.
Nature Communications, 2024
38548752 (PubMed )
Supplement: 41467_2024_45594_MOESM4_ESM.xlsx › All
Molecular profiling of pre- and post-treatment pediatric high-grade astrocytomas reveals acquired increased tumor mutation burden in a subset of recurrences.
Wood MD et al.
Acta Neuropathologica Communications, 2023
A pediatric bithalamic high grade glioma with concomitant H3K27M and EGFR mutations.
Kara B et al.
The Turkish Journal of Pediatrics, 2022
Select a paper to view details